Ledger.
Investor · San Mateo, CA

S. C. Honig

Open S. in the network graph →
Filings
32
SEC Form D
Connections
102
co-filers
Capital
$264.4M
across filings
Active
Apr 2012
to Jan 2025

Most-connected co-filers (102)

Robby Peters · San Mateo, CA24 sharedSteve B. Kim · San Mateo, CA22 sharedColin B. Tobias · San Mateo, CA20 sharedGreg Golub · San Mateo, CA18 sharedSempervirens Ventures Llc · San Mateo, CA18 sharedSempervirens Ventures Llc · San Mateo, CA18 sharedAllison B. Gates · San Mateo, CA17 sharedScott .. Dorsey · Indianapolis, IN16 sharedThomas Schnettler · Minneapolis, MN16 sharedBenedict P. Rocchio · CHICAGO, IL16 sharedChristianson J. Theodore · Minneapolis, MN16 sharedSeth D. Harward · Minneapolis, MN16 sharedMichael Leffell · New York, NY16 sharedEric Christopher · Indianapolis, IN16 sharedSteven D. Purden · Indianapolis, IN16 sharedJason Gregory · New York, NY16 sharedPSC Capital Partners LLC · Minneapolis, MN16 sharedCynthia D. Stoddard · Indianapolis, IN16 sharedByron Deeter · Denver, CO16 sharedSempervirens Capital Gp Iii Llc · San Mateo, CA9 sharedSempervirens Capital Gp Iii Llc · San Mateo, CA9 sharedCarsten D. Koppen · St Helier, Y97 sharedRandall Marshall · Newton, MA4 sharedAndrew Pearlman · Newton, MA4 shared

Recent filings (32)

SV Growth Opportunity Fund II NQP LPJan 2025 · 21 co-filersSV Growth Opportunity Fund II LPJan 2025 · 21 co-filersSemperVirens Capital Fund III NQP LPJan 2025 · 21 co-filersSemperVirens Capital Fund III LPJan 2025 · 21 co-filersSV Opportunity Fund I LPJan 2025 · 21 co-filersEumentis Therapeutics, Inc.Jun 2024 · 17 co-filers$2.0MSV Opportunity Fund I LPJan 2024 · 21 co-filersSV Growth Opportunity Fund II NQP LPJan 2024 · 21 co-filersSemperVirens Capital Fund III LPJan 2024 · 21 co-filersSV Growth Opportunity Fund II LPJan 2024 · 21 co-filersSemperVirens Capital Fund III NQP LPJan 2024 · 21 co-filersEumentis Therapeutics, Inc.Mar 2023 · 17 co-filers$20.0MSV Opportunity Fund I LPDec 2022 · 21 co-filersSV Growth Opportunity Fund II NQP LPJun 2022 · 21 co-filersEumentis Therapeutics, Inc.Apr 2022 · 16 co-filers$5.0MSV Growth Opportunity Fund II LPMar 2022 · 21 co-filersSemperVirens Capital Fund III LPMar 2022 · 21 co-filersSemperVirens Capital Fund III NQP LPMar 2022 · 21 co-filersSemperVirens Capital Fund II LPAug 2021 · 19 co-filers$50.0MSV Opportunity Fund I LPAug 2021 · 21 co-filersSPLASH BEVERAGE GROUP, INC.Feb 2021 · 8 co-filers$4.0MSPLASH BEVERAGE GROUP, INC.Jan 2021 · 8 co-filers$220KEumentis Therapeutics, Inc.Sep 2020 · 10 co-filers$3.3MSPLASH BEVERAGE GROUP, INC.Sep 2020 · 8 co-filers$3.0MSemperVirens Capital Fund II LPAug 2020 · 20 co-filers$50.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See S. in the interactive graph →